Related Experiment Video
Updated: Nov 16, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.7K
Circ_0000527 promotes osteosarcoma cell progression through modulating miR-646/ARL2 axis.
Xiangkun Wu1, Lihua Yan2, Yongxi Liu1
1Department of Orthopaedic Surgery, Nanyang Second People's Hospital, Nanyang 473000, Henan, China.
Aging
|February 22, 2021
Summary
Circular RNA circ_0000527 promotes osteosarcoma progression by regulating the miR-646/ARL2 axis. This axis influences cell growth, cell cycle, and inflammatory mediator secretion, suggesting a potential therapeutic target for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Circular RNAs (circRNAs) are increasingly recognized for their roles in human tumor development.
- Osteosarcoma is a primary bone malignancy with significant impact on young individuals.
Purpose of the Study:
- To investigate the role of circ_0000527 in osteosarcoma.
- To elucidate the molecular mechanism involving circ_0000527, miR-646, and ARL2 in osteosarcoma progression.
Main Methods:
- Quantitative real-time PCR to measure circRNA, miRNA, and mRNA levels.
- Cell proliferation and cell cycle assays.
- Western blot to detect protein expression.
- Correlation analysis in clinical osteosarcoma specimens.
Main Results:
- Circ_0000527 was significantly overexpressed in osteosarcoma tissues and cell lines.
- Circ_0000527 overexpression promoted cell growth, cell cycle progression, and secretion of inflammatory factors (IL-1β, IL-6, IL-8, TNF-α).
- Circ_0000527 acted as a sponge for miR-646, and ARL2 was identified as a target gene of miR-646. Circ_0000527 upregulated ARL2 expression by sponging miR-646.
Conclusions:
- The circ_0000527/miR-646/ARL2 axis plays a crucial role in promoting osteosarcoma cell growth, cell cycle, and inflammation.
- Targeting the circ_0000527/miR-646/ARL2 pathway represents a potential therapeutic strategy for osteosarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K
Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
PI3K/mTOR/AKT Signaling Pathway
4.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.6K
TGF - β Signaling Pathway
8.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.3K
MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs
23.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.1K

